Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P67
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -3.48% |
| Q3 2025 | -11.19% |
| Q2 2025 | -2.57% |
| Q1 2025 | -6.49% |
| Q4 2024 | -3.74% |
| Q3 2024 | -10.76% |
| Q2 2024 | -5.85% |
| Q1 2024 | 107.36% |
| Q4 2023 | 1603.37% |
| Q3 2023 | -78.70% |
| Q2 2023 | -31.52% |
| Q1 2023 | -27.91% |
| Q4 2022 | 1735.55% |
| Q3 2022 | -87.23% |
| Q2 2022 | -42.68% |
| Q1 2022 | -25.81% |
| Q4 2021 | -18.63% |
| Q3 2021 | -13.57% |
| Q2 2021 | -0.71% |
| Q1 2021 | 6.07% |
| Q4 2020 | -17.31% |
| Q3 2020 | -15.60% |
| Q2 2020 | -11.06% |
| Q1 2020 | -7.46% |
| Q4 2019 | -5.49% |
| Q3 2019 | -3.93% |
| Q2 2019 | -2.49% |
| Q1 2019 | -1.88% |
| Q4 2018 | -1.48% |
| Q3 2018 | -6.65% |
| Q2 2018 | 169.46% |
| Q1 2018 | -13.31% |
| Q4 2017 | 229.77% |
| Q3 2017 | -14.30% |
| Q2 2017 | 77.66% |
| Q1 2017 | -8.91% |
| Q4 2016 | -25.55% |
| Q3 2016 | -98.20% |
| Q2 2016 | -6.22% |
| Q1 2016 | 1859.54% |